The Use of Biomarkers in Prostate Cancer Screening and Treatment.

Author: AlfordAshley V, BritoJoseph M, RenzulliJoseph, TewariAshutosh K, YadavKamlesh K, YadavShalini S

Paper Details 
Original Abstract of the Article :
Prostate cancer screening and diagnosis has been guided by prostate-specific antigen levels for the past 25 years, but with the most recent US Preventive Services Task Force screening recommendations, as well as concerns regarding overdiagnosis and overtreatment, a new wave of prostate cancer biomar...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811879/

データ提供:米国国立医学図書館(NLM)

Biomarkers in Prostate Cancer: Guiding Diagnosis and Treatment

This research delves into the use of biomarkers in prostate cancer screening and treatment. The study examines the potential of various biomarkers, both fluid-based and biopsy-based, to aid in diagnosis, prognosis, and treatment decision-making.

Biomarkers: A New Frontier in Prostate Cancer Management

The researchers highlight the emergence of a new wave of prostate cancer biomarkers, offering a more comprehensive approach to diagnosis and treatment. They discuss 12 commercially available biomarker assays, providing insights into their clinical validation and decision-making potential.

Precision Medicine: A Tailored Approach to Prostate Cancer

Imagine a world where prostate cancer treatment is tailored to each individual's needs, like a desert traveler choosing the path that best suits their destination. This research underscores the importance of utilizing biomarkers to guide individualized treatment decisions, leading to more effective and targeted therapies.

Dr. Camel's Conclusion

This study emphasizes the transformative potential of biomarkers in prostate cancer management. By providing valuable information about risk, prognosis, and treatment options, these biomarkers are paving the way for a more personalized and effective approach to prostate cancer care.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

29472826

DOI: Digital Object Identifier

PMC5811879

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.